$8M Pharmacy NNN Acquisition | Commercial Lending Solutions 

$8 Million Pharmacy NNN Acquisition

By Trevor Damyan, Commercial Mortgage Broker at Commercial Lending Solutions

An $8 million pharmacy net lease acquisition nationwide represents a core holding for institutional and individual investors seeking stable, long-term cash flow with minimal operational risk. At this loan size, borrowers typically acquire single-location or small multi-unit pharmacy properties anchored by investment-grade or strong regional tenant covenants, with lease terms ranging from 10 to 20 years and built-in rent escalations. Lenders at this price point emphasize tenant credit quality, remaining lease term, and property location over market dynamics, resulting in leverage between 60 to 75 percent LTV and all-in rates in the 6.00 to 6.50 percent range depending on loan structure. Non-recourse availability and favorable fixed-rate terms make this product attractive to 1031 exchange buyers and core-plus portfolios alike.

Get a Quote on Your $8M Deal →

What a $8M Pharmacy NNN Acquisition Capital Stack Looks Like

National banks with established single-tenant net lease programs and life insurance companies dominate the $8 million pharmacy financing landscape, driven by their appetite for long-duration, investment-grade leases and ability to underwrite tenant credit independently of real estate cycles. Borrower profile, remaining lease term, and tenant tenant covenant strength typically determine whether a regional bank or life company leads execution, while CMBS conduits and credit unions compete on execution speed and recourse flexibility.

Capital Source Rate / Cost Size / LTV Notes
National bank with STNL program 6.00 to 6.50 percent fixed or CMT-plus-spread for ARM structures Up to $6.0 million at 65 to 70 percent LTV Prefers 15 to 20 year remaining lease term, investment-grade tenant, fixed-rate execution typical. Non-recourse available at 60 to 65 percent LTV. Fastest closing timeline, 30 to 45 days.
Life insurance company 6.10 to 6.40 percent fixed, all-in $4.0 to $8.0 million, 60 to 70 percent LTV Favorable for longer lease terms (15 to 25 years) and investment-grade tenants. Loan sizes $8M and above shift to portfolio lending arms. Full non-recourse available. Slower closing (45 to 75 days) but most favorable rate terms.
CMBS conduit 6.15 to 6.50 percent, leverage-adjusted for credit quality Full $8.0 million at 65 to 75 percent LTV Accepts investment-grade and strong regional tenants. Full recourse initially, with true non-recourse options at lower LTV. Sponsors with investment-grade leases and solid track records receive best execution. 45 to 60 day closing.
Credit union or community bank 6.25 to 6.75 percent fixed or adjustable $2.0 to $5.0 million at 60 to 70 percent LTV Relationship-focused, flexible underwriting on recourse terms. Slower aggregate volume but fastest internal approvals for local or regional borrowers. Non-recourse negotiable. 30 to 60 day close.

Pricing reflects active CLS CRE quote pipeline as of April 2026. Specific deal pricing depends on sponsor, property, and structure.

Who Closes a $8M Pharmacy NNN Acquisition Deal

Typical sponsors at the $8 million pharmacy NNN acquisition level include experienced net lease investors with $50 million to $500 million in portfolio value, multiple single-tenant acquisitions on record, and strong banking relationships. Common motivations include 1031 exchange portfolio repositioning, core-plus income allocation, and opportunistic acquisitions of high-credit tenants at favorable cap rates (4.50 to 6.00 percent range). Borrowers range from full-time CRE investment firms to high-net-worth individuals and family offices focused on passive, long-duration income.

A Real $8M Example

We closed an $8.0 million fixed-rate financing for a national pharmacy tenant operating from a secondary market property in the Upper Midwest. The sponsor, a 1031 exchange buyer, acquired the asset at a 5.50 percent cap rate with 18 years remaining on the lease and investment-grade tenant covenants. We placed the loan with a national bank offering 6.25 percent fixed at 70 percent LTV, fully non-recourse, closing in 38 days. The borrower benefited from stable monthly debt service, no recourse exposure, and flexibility to refinance in year seven as lease economics improved.

Anonymized. All deal references protect borrower and lender identity.

$8M Pharmacy NNN Acquisition FAQ

Most national banks and life companies require publicly traded or investment-grade private tenants (Moody's Baa3 and above equivalent) with EBITDA multiples above 2.5x minimum rent. Regional or secondary-market pharmacies must demonstrate 5 to 10 year operating history, stable same-store sales, and debt service coverage ratios above 1.25x at the entity level. Tenant financial statements, tax returns, and rent roll verification are underwritten in detail.
Yes. National banks and life companies typically offer true non-recourse financing at 60 to 65 percent LTV for investment-grade tenants and 15 to 20 year lease terms. CMBS conduits may require recourse on the full balance or a carve-out (typically 5 to 10 percent) at higher leverage. Borrowers accepting 60 to 65 percent LTV should expect the cleanest non-recourse terms and lowest rates.
Lenders price pharmacy net lease financing assuming tenant strength and durable income flow; default risk is minimal with investment-grade operators. At lease expiration, borrowers typically refinance based on asset quality and new tenant occupancy, or the lender may require payoff. Loan documents specify renewal expectations and landlord maintenance obligations; rent escalations and lease renewal language are scrutinized closely during underwriting.
Longer remaining lease terms (18 to 25 years) command lower rates (6.00 to 6.25 percent) and higher LTV (70 to 75 percent) because lenders face extended cash flow visibility. Leases with 10 to 15 years remaining typically cost 25 to 50 basis points more and cap LTV at 60 to 65 percent. Sponsors should prioritize lease length extension or renewal options during purchase negotiations to maximize leverage and loan economics.
National banks and credit unions typically close in 30 to 45 days; life insurance companies take 45 to 75 days due to internal investment committee approval. CMBS conduits average 45 to 60 days. Fast-tracking is possible if the borrower provides complete tax returns, entity financials, rent rolls, and lease documents upfront. Delays often occur during tenant and property due diligence, not loan structuring.


Get a Quote on Your $8M Deal

Tell us about your transaction. We will run it past lenders that actively fund this size and product type and send back terms within 48 hours.

Apply for Financing →
Or call us: 310.708.0690

Weekly Market Intelligence

Rate updates, deal insights, and capital markets analysis. One email per week. Unsubscribe anytime.

No spam. No selling your data. Just market intelligence from a working broker.

Need financing? Apply in 2 minutes. Response within 24 hours.
Apply Now →
📈

Before You Go…

Get matched with the right lender from our network of 1,000+ capital sources.

Or call us: 310.708.0690

No spam. Unsubscribe anytime.